{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:24:17Z","timestamp":1792020257843,"version":"4.4.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jaad.2024.03.024","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T22:00:00Z","timestamp":1712181600000},"page":"315-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Clinico-mycological and therapeutic updates on cutaneous dermatophytic infections in the era of Trichophyton indotineae"],"prefix":"10.1016","volume":"91","author":[{"given":"Ananta","family":"Khurana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savitha","family":"Sharath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kabir","family":"Sardana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Chowdhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2024.03.024_bib1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1473-3099(18)30079-3","article-title":"Emergence of recalcitrant dermatophytosis in India","volume":"18","author":"Bishnoi","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaad.2024.03.024_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mmcr.2022.05.004","article-title":"First detection of Trichophyton indotineae causing tinea corporis in central Vietnam","volume":"36","author":"Ngo","year":"2022","journal-title":"Med Mycol Case Rep"},{"key":"10.1016\/j.jaad.2024.03.024_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1113065","article-title":"The epidemic of the multiresistant dermatophyte Trichophyton indotineae has reached China","volume":"13","author":"Jia","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaad.2024.03.024_bib4","first-page":"460","article-title":"Trichophyton mentagrophytes\u2014a new genotype in Cambodia","volume":"5","author":"Uhrlass","year":"2019","journal-title":"J Fungi"},{"key":"10.1016\/j.jaad.2024.03.024_bib5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/jof8020150","article-title":"Increasing terbinafine resistance in Danish Trichophyton isolates 2019\u20132020","volume":"8","author":"Astvad","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.jaad.2024.03.024_bib6","first-page":"1723","article-title":"\u201cIndian\u201d strains of Trichophyton mentagrophytes with reduced itraconazole susceptibility in Germany","volume":"19","author":"Brasch","year":"2021","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2024.03.024_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3201\/eid2801.210883","article-title":"Extensive dermatophytosis caused by terbinafine-resistant Trichophyton indotineae, France","volume":"28","author":"Jabet","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jaad.2024.03.024_bib8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3390\/jof7060419","article-title":"Molecular epidemiology and antifungal susceptibility of Trichophyton isolates in Greece: emergence of terbinafine-resistant Trichophytonmentagrophytes type VIII locally and globally","volume":"7","author":"Siopi","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.jaad.2024.03.024_bib9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/12034754221077891","article-title":"Terbinafine resistant Trichophyton indotineae isolated in patients with superficial dermatophyte infection in Canadian patients","volume":"26","author":"Posso-De Los Rios","year":"2022","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2024.03.024_bib10","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2147\/IDR.S246025","article-title":"Emergence of terbinafine resistant Trichophyton mentagrophytes in Iran, harboring mutations in the squalene epoxidase (SQLE) gene","volume":"13","author":"Taghipour","year":"2020","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jaad.2024.03.024_bib11","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/jdv.17106","article-title":"Epidemiological and clinical aspects of Trichophyton mentagrophytes\/Trichophyton interdigitale infections in the Zurich area: a retrospective study using genotyping","volume":"35","author":"Klinger","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2024.03.024_bib12","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/jdv.17241","article-title":"Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic","volume":"35","author":"Saunte","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2024.03.024_bib13","doi-asserted-by":"crossref","first-page":"536","DOI":"10.15585\/mmwr.mm7219a4","article-title":"Notes from the field: first reported U.S. Cases of tinea caused by Trichophyton indotineae \u2014 New York City, December 2021\u2013March 2023","volume":"72","author":"Caplan","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaad.2024.03.024_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.fgb.2019.103255","article-title":"Antifungal resistance in dermatophytes: recent trends and therapeutic implications","volume":"132","author":"Khurana","year":"2019","journal-title":"Fungal Genet Biol"},{"key":"10.1016\/j.jaad.2024.03.024_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010795","article-title":"The emergence and worldwide spread of the species Trichophyton indotineae causing difficult-to-treat dermatophytosis: a new challenge in the management of dermatophytosis","volume":"18","author":"Chowdhary","year":"2022","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jaad.2024.03.024_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/myc.12865","article-title":"Perspectives on misidentification of Trichophyton interdigitale\/Trichophyton mentagrophytes using internal transcribed spacer region sequencing: urgent need to update the sequence database","volume":"62","author":"Chowdhary","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.jaad.2024.03.024_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02522-17","article-title":"Mutation in the squalene epoxidase gene of Trichophyton interdigitale and Trichophyton rubrum associated with allylamine resistance","volume":"62","author":"Rudramurthy","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2024.03.024_bib18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/myc.12772","article-title":"High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene","volume":"61","author":"Singh","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.jaad.2024.03.024_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.fgb.2019.103266","article-title":"A unique multidrug-resistant clonal Trichophyton population distinct from Trichophyton mentagrophytes\/Trichophyton interdigitale complex causing an ongoing alarming dermatophytosis outbreak in India: genomic insights and resistance profile","volume":"133","author":"Singh","year":"2019","journal-title":"Fungal Genet Biol"},{"key":"10.1016\/j.jaad.2024.03.024_bib20","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s11046-020-00455-8","article-title":"Trichophyton indotineae sp. nov.: a new highly terbinafine-resistant anthropophilic dermatophyte species","volume":"185","author":"Kano","year":"2020","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jaad.2024.03.024_bib21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11046-021-00544-2","article-title":"Taxonomy of the Trichophyton mentagrophytes\/T. Interdigitale species complex harboring the highly virulent, multiresistant genotype T. Indotineae","volume":"186","author":"Tang","year":"2021","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jaad.2024.03.024_bib22","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/myc.13367","article-title":"Predicting a therapeutic cut-off serum level of itraconazole in recalcitrant tinea corporis and cruris\u2014a prospective trial","volume":"64","author":"Khurana","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.jaad.2024.03.024_bib23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4103\/ijd.IJD_548_19","article-title":"Efficacy of terbinafine and itraconazole in different doses and in combination in the treatment of tinea infection: a randomized controlled parallel group open labeled trial with clinico-mycological correlation","volume":"65","author":"Singh","year":"2020","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.jaad.2024.03.024_bib24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/ijp.IJP_578_17","article-title":"Efficacy of oral terbinafine versus itraconazole in treatment of dermatophytic infection of skin-A prospective, randomized comparative study","volume":"51","author":"Bhatia","year":"2019","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.jaad.2024.03.024_bib26","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1111\/1346-8138.15300","article-title":"Caution and warning: arrival of terbinafine-resistant Trichophyton interdigitale of the Indian genotype, isolated from extensive dermatophytosis, in Japan","volume":"47","author":"Kimura","year":"2020","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2024.03.024_bib27","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3390\/jof8070757","article-title":"Trichophyton indotineae-an emerging pathogen causing recalcitrant dermatophytoses in India and worldwide-A multidimensional perspective","volume":"8","author":"Uhrla\u00df","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.jaad.2024.03.024_bib28","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/myc.12878","article-title":"The current Indian epidemic of superficial dermatophytosis due to Trichophyton mentagrophytes-A molecular study","volume":"62","author":"Nenoff","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.jaad.2024.03.024_bib29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/myc.13091","article-title":"Alarming India-wide phenomenon of antifungal resistance in dermatophytes: a multicentre study","volume":"63","author":"Ebert","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.jaad.2024.03.024_bib30","article-title":"Correlation of in\u00a0vitro susceptibility based on MICs and squalene epoxidase mutations with clinical response to terbinafine in patients with tinea corporis\/cruris","volume":"6","author":"Khurana","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2024.03.024_bib31","article-title":"Antifungal susceptibility and mutations in the squalene epoxidase gene in dermatophytes of the Trichophyton mentagrophytes species complex","volume":"6","author":"Kong","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2024.03.024_bib32","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/myc.13150","article-title":"Indian Trichophyton mentagrophytes squalene epoxidase erg1 double mutants show high proportion of combined fluconazole and terbinafine resistance","volume":"63","author":"Burmester","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.jaad.2024.03.024_bib33","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/ijd.16622","article-title":"Treatment recalcitrant cases of tinea corporis\/cruris caused by T. mentagrophytes \u2013 interdigitale complex with mutations in ERG11 ERG 3, ERG4, MDR1 MFS genes & SQLE and their potential implications","volume":"62","author":"Bhattacharyya","year":"2023","journal-title":"Int J Dermatology"},{"key":"10.1016\/j.jaad.2024.03.024_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00059-22","article-title":"Gene amplification of CYP51B: a new mechanism of resistance to azole compounds in Trichophyton indotineae","volume":"66","author":"Yamada","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2024.03.024_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00933-23","article-title":"Two different types of tandem sequences mediate the overexpression of TinCYP51B in azole-resistant Trichophyton indotineae","volume":"67","author":"Yamada","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2024.03.024_bib36","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/jamadermatol.2022.3745","article-title":"Effect of different itraconazole dosing regimens on cure rates, treatment duration, safety, and relapse rates in adult patients with tinea corporis\/cruris: a randomized clinical trial","volume":"158","author":"Khurana","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2024.03.024_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14891","article-title":"Re-emerging role of KOH smear examination in the era of recalcitrant dermatophytoses","volume":"34","author":"Khurana","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2024.03.024_bib38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000515290","article-title":"The emerging terbinafine-resistant Trichophyton epidemic: what is the role of antifungal susceptibility testing?","volume":"238","author":"Shen","year":"2022","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2024.03.024_bib39","series-title":"Dermatophytes and Dermatophytoses","first-page":"401","article-title":"Antifungal susceptibility testing of dermatophytes","author":"Wiederhold","year":"2021"},{"key":"10.1016\/j.jaad.2024.03.024_bib40","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/bjd.19562","article-title":"The science and rationale of arriving at the correct drug and dosimetry of griseofulvin, fluconazole, terbinafine and itraconazole in superficial dermatophyte infections: an important step before a pragmatic trial","volume":"184","author":"Sardana","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2024.03.024_bib41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/00003495-199243020-00010","article-title":"Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses","volume":"43","author":"Balfour","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2024.03.024_bib42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/bst0180045","article-title":"Inhibition of squalene epoxidase and sterol side-chain methylation by allylamines","volume":"18","author":"Ryder","year":"1990","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jaad.2024.03.024_bib43","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2230.1989.tb00908.x","article-title":"Clinical efficacy and tolerability of terbinafine (Lamisil)--a new topical and systemic fungicidal drug for treatment of dermatomycoses","volume":"14","author":"Villars","year":"1989","journal-title":"Clin Exp Dermatology"},{"key":"10.1016\/j.jaad.2024.03.024_bib44","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archderm.1989.01670230079013","article-title":"A comparison of a new oral antifungal, terbinafine, with griseofulvin as therapy for tinea corporis","volume":"125","author":"Cole","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2024.03.024_bib45","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1365-2133.1994.tb04983.x","article-title":"One-week therapy with oral terbinafine in cases of tinea cruris\/corporis","volume":"131","author":"Farag","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2024.03.024_bib46","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4103\/0019-5154.190120","article-title":"Relapse after oral terbinafine therapy in dermatophytosis: a clinical and mycological study","volume":"61","author":"Majid","year":"2016","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.jaad.2024.03.024_bib47","doi-asserted-by":"crossref","first-page":"820","DOI":"10.4103\/idoj.IDOJ_167_21","article-title":"Oral isotretinoin combined with oral terbinafine versus oral terbinafine alone to treat recurrent dermatophytosis: an open-label randomised clinical trial","volume":"12","author":"Verma","year":"2021","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jaad.2024.03.024_bib48","doi-asserted-by":"crossref","first-page":"665","DOI":"10.25259\/IJDVL_74_2022","article-title":"Efficacy and safety of 250 mg versus 500 mg oral terbinafine in the treatment of tinea corporis and cruris: a randomised, assessor-blinded comparative study","volume":"89","author":"Lal","year":"2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2024.03.024_bib49","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4103\/ijd.ijd_832_23","article-title":"Therapeutic updates on the management of tinea corporis or cruris in the era of Trichophyton Indotineae: separating evidence from hype\u2014a narrative review","volume":"68","author":"Khurana","year":"2023","journal-title":"Ind J Dermatol"},{"key":"10.1016\/j.jaad.2024.03.024_bib50","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000246883","article-title":"Clinical experience with short schedules of itraconazole in the treatment of tinea corporis and\/or tinea cruris","volume":"189","author":"Parent","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2024.03.024_bib51","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1439-0507.1998.tb00714.x","article-title":"Itraconazole in the treatment of tinea corporis and tinea cruris: comparison of two treatment schedules","volume":"41","author":"Boonk","year":"1998","journal-title":"Mycoses"},{"key":"10.1016\/j.jaad.2024.03.024_bib52","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/bjd.19146","article-title":"Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial","volume":"183","author":"Singh","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2024.03.024_bib53","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkt508","article-title":"Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology","volume":"69","author":"Ashbee","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jaad.2024.03.024_bib54","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/myc.13551","article-title":"Correlation of plasma levels of itraconazole with treatment response at 4weeks in chronic dermatophytosis: results of a randomised controlled trial","volume":"66","author":"Bhalavi","year":"2023","journal-title":"Mycoses"},{"key":"10.1016\/j.jaad.2024.03.024_bib55","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/17512433.2019.1604218","article-title":"Parameters that determine dissolution and efficacy of itraconazole and its relevance to recalcitrant dermatophytoses","volume":"12","author":"Sardana","year":"2019","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.jaad.2024.03.024_bib56","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4103\/idoj.IDOJ_339_17","article-title":"A pilot analysis of morphometric assessment of itraconazole brands using dermoscopy and its relevance in the current scenario","volume":"9","author":"Sardana","year":"2018","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jaad.2024.03.024_bib57","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1080\/09546634.2019.1708848","article-title":"An exploratory pilot analysis of the optimal pellet number in 100 mg of itraconazole capsule to maximize the surface area to satisfy the Noyes-Whitney equation","volume":"32","author":"Sardana","year":"2021","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.jaad.2024.03.024_bib58","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1128\/AAC.00973-15","article-title":"Population pharmacokinetic modeling of itraconazole and hydroxyitraconazole for oral SUBA-itraconazole and sporanox capsule formulations in healthy subjects in fed and fasted states","volume":"59","author":"Abuhelwa","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2024.03.024_bib59","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2022-8-1","article-title":"Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis","volume":"12","author":"Dhoot","year":"2023","journal-title":"Drugs Context"},{"key":"10.1016\/j.jaad.2024.03.024_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.mycmed.2022.101306","article-title":"Multidrug resistant tinea corporis\/cruris: response to voriconazole","volume":"32","author":"Khurana","year":"2022","journal-title":"J Mycol Med"},{"key":"10.1016\/j.jaad.2024.03.024_bib62","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/ijd.15226","article-title":"Multidrug-resistant Trichophyton mentagrophytes genotype VIII in an Iranian family with generalized dermatophytosis: report of four cases and review of literature","volume":"60","author":"Fattahi","year":"2021","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2024.03.024_bib63","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/ced.14799","article-title":"Evaluation of efficacy and safety of oral voriconazole in the management of recalcitrant and recurrent dermatophytosis","volume":"47","author":"Chandrashekar","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2024.03.024_bib64","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/myc.13517","article-title":"Voriconazole is superior to combined itraconazole\/isotretinoin therapy and itraconazole monotherapy in recalcitrant dermatophytosis","volume":"65","author":"Khattab","year":"2022","journal-title":"Mycoses"},{"key":"10.1016\/j.jaad.2024.03.024_bib65","first-page":"17","article-title":"Efficacy of voriconazole among 500 dermatophytes patients: a study in a Tertiary Care Hospital, Cumilla, Bangladesh","volume":"9","author":"Hoq","year":"2020","journal-title":"Am J Dermatol Venereol"},{"key":"10.1016\/j.jaad.2024.03.024_bib66","doi-asserted-by":"crossref","first-page":"330","DOI":"10.53350\/pjmhs22162330","article-title":"Efficacy of oral voriconazole in the treatment of dermatophyte infections (Tinea Corporis and Cruris)","volume":"16","author":"Shahzad","year":"2022","journal-title":"Pakistan J Medical Health Sci"},{"key":"10.1016\/j.jaad.2024.03.024_bib67","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/jac\/dkw045","article-title":"Trough concentration of voriconazole and its relationship with efficacy and safety \u2212 A systematic review and meta-analysis","volume":"71","author":"Jin","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jaad.2024.03.024_bib68","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/bjd.19420","article-title":"Treatment-resistant tinea corporis, a potential public health issue","volume":"184","author":"Chen","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2024.03.024_bib69","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1001\/jamadermatol.2014.2154","article-title":"Posaconazole treatment of extensive skin and nail dermatophytosis due to autosomal recessive deficiency of CARD9","volume":"151","author":"Jachiet","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2024.03.024_bib70","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0190-9622(82)70037-4","article-title":"Oral ketoconazole for dermatophyte infections","volume":"6","author":"Cox","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2024.03.024_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-198223010-00001","article-title":"Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections","volume":"23","author":"Heel","year":"1982","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2024.03.024_bib72","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1177\/1203475415574970","article-title":"The rise and fall of oral ketoconazole","volume":"19","author":"Gupta","year":"2015","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2024.03.024_bib73","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4269\/ajtmh.21-0505","article-title":"Real world analysis of response rate and efficacy of oral ketoconazole in patients with recalcitrant tinea corporis and cruris","volume":"106","author":"Arora","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jaad.2024.03.024_bib74","first-page":"103","article-title":"Griseofulvin: biology and clinical usefulness. A review","volume":"23","author":"Anderson","year":"1965","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaad.2024.03.024_bib75","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000247498","article-title":"Itraconazole compared with griseofulvin in the treatment of tinea corporis\/cruris and tinea pedis\/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile","volume":"184","author":"Lachapelle","year":"1992","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2024.03.024_bib76","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1001\/archderm.1981.01650010022016","article-title":"Griseofulvin-resistant dermatophytosis correlates with in\u00a0vitro resistance","volume":"117","author":"Artis","year":"1981","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2024.03.024_bib77","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00321-21","article-title":"Checkerboard analysis to evaluate synergistic combinations of existing antifungal drugs and propylene glycol monocaprylate in isolates from recalcitrant tinea corporis and cruris patients harboring squalene epoxidase gene mutation","volume":"65","author":"Sardana","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2024.03.024_bib78","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01449-21","article-title":"In\u00a0vitro antifungal combination of terbinafine with itraconazole against isolates of Trichophyton species","volume":"66","author":"Bidaud","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2024.03.024_bib79","doi-asserted-by":"crossref","DOI":"10.1111\/myc.13681","article-title":"Evaluation of the benefit of the addition of 1% topical luliconazole versus topical bland emollient to the systemic itraconazole therapy for the management of disseminated dermatophytosis: a randomised control trial","volume":"67","author":"Rana","year":"2024","journal-title":"Mycoses"},{"key":"10.1016\/j.jaad.2024.03.024_bib80","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/ijdvl.IJDVL_807_17","article-title":"Risk factors for chronic and chronic-relapsing tinea corporis, tinea cruris and tinea faciei: results of a case-control study","volume":"85","author":"Singh","year":"2019","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2024.03.024_bib81","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/myc.13625","article-title":"Revisiting the pathogenesis of dermatophytosis: a cross-sectional analytic study of serum levels of interleukins-2, 8, 10 and 17","volume":"66","author":"Dev","year":"2023","journal-title":"Mycoses"},{"key":"10.1016\/j.jaad.2024.03.024_bib82","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/myc.13479","article-title":"Comparative evaluation of host immune response and cytokine signature pertaining to Th1 and Th2 immune arms in serum and tissue among patients of acute localised vs. chronic disseminated dermatophytosis","volume":"65","author":"Patel","year":"2022","journal-title":"Mycoses"},{"key":"10.1016\/j.jaad.2024.03.024_bib83","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4103\/idoj.IDOJ_503_20","article-title":"Immunopathogenesis of dermatophytoses and factors leading to recalcitrant infections","volume":"12","author":"Sardana","year":"2021","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jaad.2024.03.024_bib84","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/14787210.2023.2250555","article-title":"An update on the myriad antifungal resistance mechanisms in dermatophytes and the place of experimental and existential therapeutic agents for Trichophyton complex implicated in tinea corporis and cruris","volume":"21","author":"Sardana","year":"2023","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jaad.2024.03.024_bib85","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/jac\/dkaa562","article-title":"In\u00a0vitro activity of the novel antifungal olorofim against dermatophytes and opportunistic moulds including Penicillium and Talaromyces species","volume":"76","author":"Singh","year":"2021","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224005358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224005358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T16:52:03Z","timestamp":1731689523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962224005358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0190962224005358"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2024.03.024","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinico-mycological and therapeutic updates on cutaneous dermatophytic infections in the era of Trichophyton indotineae","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}